Lifecare AS (LIFE) - Net Assets
Based on the latest financial reports, Lifecare AS (LIFE) has net assets worth Nkr-6.66 Million NOK (≈ $-700.93K USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr85.47 Million ≈ $8.99 Million USD) and total liabilities (Nkr92.13 Million ≈ $9.69 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Lifecare AS's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Nkr-6.66 Million |
| % of Total Assets | -7.79% |
| Annual Growth Rate | 52.21% |
| 5-Year Change | 455.12% |
| 10-Year Change | N/A |
| Growth Volatility | 142.64 |
Lifecare AS - Net Assets Trend (2015–2024)
This chart illustrates how Lifecare AS's net assets have evolved over time, based on quarterly financial data. Also explore Lifecare AS balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for Lifecare AS (2015–2024)
The table below shows the annual net assets of Lifecare AS from 2015 to 2024. For live valuation and market cap data, see how much is Lifecare AS worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Nkr73.98 Million ≈ $7.78 Million |
+11.32% |
| 2023-12-31 | Nkr66.45 Million ≈ $6.99 Million |
+20.28% |
| 2022-12-31 | Nkr55.25 Million ≈ $5.81 Million |
+127.88% |
| 2021-12-31 | Nkr24.25 Million ≈ $2.55 Million |
+81.94% |
| 2020-12-31 | Nkr13.33 Million ≈ $1.40 Million |
-15.30% |
| 2019-12-31 | Nkr15.73 Million ≈ $1.66 Million |
-29.26% |
| 2018-12-31 | Nkr22.24 Million ≈ $2.34 Million |
+1045.89% |
| 2017-12-31 | Nkr-2.35 Million ≈ $-247.41K |
-377.11% |
| 2016-12-31 | Nkr848.46K ≈ $89.28K |
-49.65% |
| 2015-12-31 | Nkr1.69 Million ≈ $177.32K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Lifecare AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 128914400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Nkr82.44 Million | 110.78% |
| Other Comprehensive Income | Nkr1.00K | 0.00% |
| Other Components | Nkr8.04 Million | 10.81% |
| Total Equity | Nkr74.41 Million | 100.00% |
Lifecare AS Competitors by Market Cap
The table below lists competitors of Lifecare AS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
OCEAN-GEOLOOP AS NK -01
F:FQ4
|
$8.01 Million |
|
Miraculum SA
WAR:MIR
|
$8.03 Million |
|
VERSES AI Inc.
NEO:VERS
|
$8.03 Million |
|
TruCap Finance Limited
NSE:TRU
|
$8.03 Million |
|
Falmaco Nonwoven Industri PT Tbk
JK:FLMC
|
$8.01 Million |
|
Ajooni Biotech Limited
NSE:AJOONI
|
$8.01 Million |
|
Sanko Diecasting (Thailand) Public Company Limited
BK:SANKO
|
$7.99 Million |
|
Nigbas Nigde Beton Sanayi ve Ticaret AS
IS:NIBAS
|
$7.99 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lifecare AS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 66,402,426 to 74,410,000, a change of 8,007,574 (12.1%).
- Net loss of 71,757,000 reduced equity.
- New share issuances of 106,625,000 increased equity.
- Other comprehensive income increased equity by 1,000.
- Other factors decreased equity by 26,861,426.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Nkr-71.76 Million | -96.43% |
| Share Issuances | Nkr106.62 Million | +143.29% |
| Other Comprehensive Income | Nkr1.00K | +0.0% |
| Other Changes | Nkr-26.86 Million | -36.1% |
| Total Change | Nkr- | 12.06% |
Book Value vs Market Value Analysis
This analysis compares Lifecare AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.07x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.31x to 0.07x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | Nkr0.30 | Nkr0.40 | x |
| 2016-12-31 | Nkr0.15 | Nkr0.40 | x |
| 2017-12-31 | Nkr-0.42 | Nkr0.40 | x |
| 2018-12-31 | Nkr2.75 | Nkr0.40 | x |
| 2019-12-31 | Nkr1.94 | Nkr0.40 | x |
| 2020-12-31 | Nkr1.48 | Nkr0.40 | x |
| 2021-12-31 | Nkr2.70 | Nkr0.40 | x |
| 2022-12-31 | Nkr4.79 | Nkr0.40 | x |
| 2023-12-31 | Nkr7.17 | Nkr0.40 | x |
| 2024-12-31 | Nkr5.83 | Nkr0.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lifecare AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -96.43%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2367.44%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 1.51x
- Recent ROE (-96.43%) is above the historical average (-138.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -444.70% | -192.44% | 1.71x | 1.35x | Nkr-7.66 Million |
| 2016 | -588.64% | -309.46% | 0.87x | 2.19x | Nkr-5.08 Million |
| 2017 | 0.00% | -622.56% | 0.46x | 0.00x | Nkr-3.20 Million |
| 2018 | -39.54% | -252.25% | 0.15x | 1.05x | Nkr-11.02 Million |
| 2019 | -41.67% | -316.87% | 0.12x | 1.11x | Nkr-8.13 Million |
| 2020 | -20.57% | -163.88% | 0.11x | 1.10x | Nkr-4.07 Million |
| 2021 | -65.48% | -4894.06% | 0.01x | 1.33x | Nkr-18.30 Million |
| 2022 | -30.97% | -104.56% | 0.24x | 1.24x | Nkr-23.12 Million |
| 2023 | -53.10% | -269.43% | 0.15x | 1.30x | Nkr-41.90 Million |
| 2024 | -96.43% | -2367.44% | 0.03x | 1.51x | Nkr-79.20 Million |
Industry Comparison
This section compares Lifecare AS's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $142,816,617
- Average return on equity (ROE) among peers: 9.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lifecare AS (LIFE) | Nkr-6.66 Million | -444.70% | N/A | $8.01 Million |
| Gentian Diagnostics AS (GENT) | $174.77 Million | -14.19% | 0.21x | $61.34 Million |
| Medistim ASA (MEDI) | $236.86 Million | 29.68% | 0.42x | $438.41 Million |
| Observe Medical Asa (OBSRV) | $16.82 Million | 13.52% | 2.50x | $15.19 Million |
About Lifecare AS
Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures … Read more